EN | UA
EN | UA

Help Support

Back

Dextrose prolotherapy vs. Triamcinolone injection for management of knee osteoarthritis

Dextrose prolotherapy Dextrose prolotherapy
Dextrose prolotherapy Dextrose prolotherapy

An intra-articular Triamcinolone injection and a combination of intra- and extraarticular Dextrose prolotherapy were examined to determine the therapeutic effects on osteoarthritis of the knee in a randomized clinical trial.

See All

Key take away

People with knee osteoarthritis benefit both in the short and midterm from a combination of intra-articular and neurofascial Dextrose prolotherapy.

Background

An intra-articular Triamcinolone injection and a combination of intra- and extraarticular Dextrose prolotherapy were examined to determine the therapeutic effects on osteoarthritis of the knee in a randomized clinical trial.

Method

Overall, 50 knee osteoarthritis subjects were segregated into 2 groups. The 1st group got Dextrose prolotherapy in the form of 1 intra-articular injection of 10cc 16% Dextrose and periarticular intradermal injections of 12% Dextrose at four sites surrounding the knee (2.5 cc at each position). Triamcinolone (40 mg) was injected intra-articularly for the second group.

Result

Both therapies significantly reduced pain (assessed by visual analog scale [VAS]) and Western Ontario and McMaster Universities Arthritis (WOMAC) (all of its components) at 1 and 3 months post-intervention compared to pre-treatment. The corticosteroid group exhibited superior pain reduction in the first month. The prolotherapy group showed substantially higher improvements in the VAS and WOMAC components in the third post-intervention month (Table 1).

Conclusion

Individuals having knee osteoarthritis can benefit from both corticosteroid and Dextrose prolotherapy (combination of intra and extraarticular approaches) in terms of pain relief and functional improvement. The prolotherapy approach was less efficient in reducing pain in the short term than corticosteroids, but its benefits lasted longer, and in midterm tests (3 months), it outperformed corticosteroids.

Source:

Anesthesiology and Pain Medicine

Article:

Comparison of Dextrose Prolotherapy and Triamcinolone Intraarticular Injection on Pain and Function in Patients with Knee Osteoarthritis - A Randomized Clinical Trial

Authors:

Masume Bayat et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: